14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
ASPSZ vs BDMDW
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ASPSZ vs BDMDW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
BDMDW Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)
BDMDW Overall Winner
6-Pillar Tally: ASPSZ 0 – 0 BDMDW (6 Tie)
Matrix Metrics: ASPSZ 2 – 1 BDMDW
As of Nov 20, 2026, Baird Medical Investment Holdings Ltd Warrant (BDMDW) is the stronger overall head-to-head candidate over Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ASPSZ carries a Unified Composite Score of 47.1/100 (HOLD) at $0.18 (N/M Forward P/E, N/A operating margin), whereas BDMDW carries 48.8/100 (HOLD) at $0.02 (N/M Forward P/E, N/A operating margin).
ASPSZ
NASDAQ
Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants
Services-Miscellaneous Business Services
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.76β · 196% Vol
Unified Composite Score
47.1 / 100
HOLD
Tech 40.0
Fund 42.0
Flow 50.0
Mom 70.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.5 · SMA20: $0.18 · SMA50: $0.17
BDMDW
NASDAQ
Head-to-Head Winner
Baird Medical Investment Holdings Ltd Warrant
Institutional Equity
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
-0.19β · 641% Vol
Unified Composite Score
48.8 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
6-Pillar Scorecard Institutional Category Breakdown (ASPSZ 0 – 0 BDMDW)
Columns: Metric · ASPSZ · BDMDW
1. Valuation Multiples
Tie
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
N/M
N/M
2. Growth & Scale
Tie
Revenue Growth (YoY)
N/A
N/A
Earnings Growth (YoY)
N/A
N/A
TTM Revenue (USD)
N/A
N/A
Market Cap
N/A
N/A
3. Profitability & Quality
Tie
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Net Profit Margin
N/A
N/A
Return on Equity (ROE)
N/A
N/A
4. Balance Sheet & Cash Flow
Tie
Cash Generation (TTM)
N/A
N/A
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
N/A ROE
N/A ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Services-Miscellaneous Business Services Operator
Institutional Equity Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ASPSZ (2) vs BDMDW (1)
Institutional Metric
ASPSZ
BDMDW
Criterion
Row Edge
Market Capitalization
Scale
N/A
N/A
Larger Scale
Tie
Trailing P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Forward P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Revenue Growth (YoY)
Growth
N/A
N/A
Higher Growth
Tie
Operating Margin (TTM)
Profitability
N/A
N/A
Higher Margin
Tie
Net Profit Margin
Profitability
N/A
N/A
Higher Margin
Tie
Return on Equity (ROE)
Capital Efficiency
N/A
N/A
Higher ROE
Tie
52-Week Range Position
Momentum
13% ($0–$1)
2% ($0–$0)
Stronger Trend
ASPSZ
Beta / 30D Volatility
Risk Regime
0.76β · 196% Vol
-0.19β · 641% Vol
Lower Realized Risk
ASPSZ
Unified Institutional Score
Composite Signal
47.1 / 100 (HOLD)
48.8 / 100 (HOLD)
Higher Composite
BDMDW
Trailing 12M Revenue (USD)
Operating Scale
N/A
N/A
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A
N/A
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev
N/M PEG · N/M EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE)
N/A (N/A ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
ASPSZ +22.21 pp
ASPSZ:
-42.88%
·
BDMDW:
-65.09%
3M Horizon
ASPSZ +46.95 pp
ASPSZ:
-21.74%
·
BDMDW:
-68.69%
6M Horizon
ASPSZ +5.37 pp
ASPSZ:
-63.69%
·
BDMDW:
-69.06%
1Y Horizon
ASPSZ +5.37 pp
ASPSZ:
-63.69%
·
BDMDW:
-69.06%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ASPSZ vs BDMDW. Trailing 12-month operating profitability (ASPSZ N/A vs BDMDW N/A) and valuation multiples (ASPSZ N/M vs BDMDW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
ASPSZ ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
BDMDW ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
ASPSZ
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
BDMDW
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
ASPSZ Moat Profile
Cyclical / Execution-Driven Positioning
Services-Miscellaneous Business Services Operator
Competes within the Services-Miscellaneous Business Services value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
BDMDW Moat Profile
Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ ASPSZ vs BDMDW Key Questions & Quantitative Answers
Is ASPSZ or BDMDW a better stock to buy right now?
As of Nov 20, 2026, Baird Medical Investment Holdings Ltd Warrant (BDMDW) is the stronger overall head-to-head candidate over Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ASPSZ carries a Unified Composite Score of 47.1/100 (HOLD) at $0.18 (N/M Forward P/E, N/A operating margin), whereas BDMDW carries 48.8/100 (HOLD) at $0.02 (N/M Forward P/E, N/A operating margin). Technically, ASPSZ sits in a Neutral phase (RSI 50.5, UNCLASSIFIED options structure) and BDMDW sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure).
Does ASPSZ or BDMDW have stronger revenue and earnings growth?
ASPSZ and BDMDW split Growth & Scale metrics: ASPSZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BDMDW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ASPSZ generates N/A in USD-normalized revenue versus N/A for BDMDW. In operating R&D and SG&A reinvestment, ASPSZ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BDMDW.
Is ASPSZ or BDMDW cheaper on valuation?
ASPSZ and BDMDW trade at balanced relative valuation multiples. ASPSZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BDMDW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ASPSZ (N/A ROE) versus BDMDW (N/A ROE) capital efficiency.
How is options market volatility positioned on ASPSZ vs BDMDW?
In options market volatility and institutional positioning, ASPSZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.76β · 196% Vol realized risk). By comparison, BDMDW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.19β · 641% Vol realized risk).
Altisource Portfolio Solutions S.A. Cash Exercise Stakeholder Warrants (ASPSZ) Research Suite
Baird Medical Investment Holdings Ltd Warrant (BDMDW) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.